Patents matching “antibody”

US 10189901

Methods for improving cardiac function by administering an antibody that activates APLNR

REGENERON PHARMACEUTICALS, INC. · Granted Jan 29, 2019 · Expires Jan 24, 2039

US 10166304

Antibody fragments for detecting cancer and methods of use

Regents of the University of Minnesota · Granted Jan 1, 2019 · Expires Dec 27, 2038

IL 240179

Use of a monoclonal, chimeric, human antibody that binds il-5r in the manufacture of a medicament for reducing the numbers of blood basophils in a human subject

BIOWA INC [US] · Granted Dec 31, 2018 · Expires Dec 26, 2038

US 10149903

Fully human antibody against respiratory syncytical virus

ELITEIMMUNE INC. · Granted Dec 11, 2018 · Expires Dec 6, 2038

US 10118961

Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV

CytomX Therapeutics, Inc. · Granted Nov 6, 2018 · Expires Nov 1, 2038

US 10087240

DNA antibody constructs and method of using same

Inovio Pharmaceuticals, Inc. · Granted Oct 2, 2018 · Expires Sep 27, 2038

US 10071168

Polyoxazoline antibody drug conjugates

Serina Therapeutics, Inc. · Granted Sep 11, 2018 · Expires Sep 6, 2038

US 10072070

Potent anti-influenza A neuraminidase subtype N1 antibody

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 11, 2018 · Expires Sep 6, 2038

US 10053514

Human bispecific EGFRvIII and CD3 antibody engaging molecules

The United States of America as Represented by the Secretary of Health and Human Services, National Institutes of Health · Granted Aug 21, 2018 · Expires Aug 16, 2038

US 10035848

Antibody targeting cell surface deposited complement protein C3d and use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 31, 2018 · Expires Jul 26, 2038

US 10018638

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

The Board of Regents of the University of Texas System · Granted Jul 10, 2018 · Expires Jul 5, 2038

US 10010587

IL-2Rβ-selective agonists in combination with an anti-CTLA-4 antibody or an anti-PD-1 antibody

Nektar Therapeutics · Granted Jul 3, 2018 · Expires Jun 28, 2038

US 10004800

Antibody evolution immunogens

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Jun 26, 2018 · Expires Jun 21, 2038

US 9975952

Antibody fragments, compositions and uses thereof

METIS PRECISION MEDICINE SB S.R.L. · Granted May 22, 2018 · Expires May 17, 2038

US 9968674

Methods and compositions comprising a combination of a VEGF Trap and an anti-CTLA-4 antibody

REGENERON PHARMACEUTICALS, INC. · Granted May 15, 2018 · Expires May 10, 2038

US 9951141

Antibody-drug conjugates, their preparation and their therapeutic use

REGENERON PHARMACEUTICALS, INC. · Granted Apr 24, 2018 · Expires Apr 19, 2038

US 9938339

Method for treating an eye disease or disorder by administering an antibody that binds angiopoietin-2

REGENERON PHARMACEUTICALS, INC. · Granted Apr 10, 2018 · Expires Apr 5, 2038

US 9938350

Receptor tyrosine kinase-like orphan receptor 1 (ROR1) single chain Fv antibody fragment conjugates and methods of use thereof

The Regents of the University of California · Granted Apr 10, 2018 · Expires Apr 5, 2038

US 9931414

Pyrrolobenzodiazepine-antibody conjugates

ADC THERAPEUTICS SA · Granted Apr 3, 2018 · Expires Mar 29, 2038

US 9931415

Pyrrolobenzodiazepine-antibody conjugates

ADC THERAPEUTICS SA · Granted Apr 3, 2018 · Expires Mar 29, 2038

US 9926369

Methods for treating hepatocellular cancer by administering an anti-Ang-2 antibody

REGENERON PHARMACEUTICALS, INC. · Granted Mar 27, 2018 · Expires Mar 22, 2038

US 9919056

Pyrrolobenzodiazepine-anti-CD22 antibody conjugates

ADC THERAPEUTICS SA · Granted Mar 20, 2018 · Expires Mar 15, 2038

US 9915668

Antibody based reagents that specifically recognize toxic oligomeric forms of tau

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Mar 13, 2018 · Expires Mar 8, 2038

US 9856313

Epitope of RSV fusion protein and antibody recognizing the same

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 2, 2018 · Expires Dec 28, 2037